MACHYPO
Food supplement declared in France, declaration No 2024-3-1103, decision dated 20 March 2024
MACHYPO (Institut Astarté) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- Institut Astarté
- Food business operator placing the product on the market
- Institut Astarté
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Compte-gouttes
- Daily dose
- 5 à 15 gouttes
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Insuffisance rénale, Problèmes cardiaques
- Objectives stated by the manufacturer (these are not authorised claims)
- Antioxydant, Circulation sanguine et lymphatique
Declaration 140234, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Olea europaea subsp. europaea | Feuille | Alcoolature | 20 mg |
| Equisetum arvense L. | Parties aériennes | Alcoolature | 20 mg |
| Vitis vinifera L. | Feuille | Alcoolature | 20 mg |
| Crataegus monogyna Jacq. | Feuille | Alcoolature | 10 mg |
| Crataegus laevigata (Poir.) DC. | Bourgeon | Alcoolature | 3 mg |
Other ingredients
Alcool
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging
Label warnings
Alcool 45%
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Brand : Institut Astarté